Jyothy Labs schedules one-on-one investor meet on September 8

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Jyothy Laboratories meets V.E.C Investment Management on September 8, 2026
  • The one-on-one session follows SEBI Regulation 30 disclosure norms
  • Company confirms no UPSI will be shared during the interaction
powered bylight_fuzz_icon
50066991

*this image is generated using AI for illustrative purposes only.

Jyothy Laboratories has scheduled a one-on-one meeting with V.E.C Investment Management (India) Private Limited on September 8, 2026.

Meeting details

The engagement is part of the company’s standard investor relations activity under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Representatives of Jyothy Labs Limited will attend the session.

Parameter Details
Event One-on-one meeting with analysts and investors
Date September 8, 2026
Investor V.E.C Investment Management (India) Private Limited
Company Jyothy Laboratories

The company stated that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during the meeting. The schedule may change due to exigencies on the part of the investor or the company. The latest Investor Presentation is available on the company website.

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.52%-3.81%-2.19%-18.01%-40.08%+19.71%

How might Jyothy Laboratories' recent performance in the FMCG and personal care segments influence investor sentiment during this meeting?

What strategic initiatives or growth verticals is Jyothy Labs likely to highlight to V.E.C Investment Management given the current competitive landscape?

Could this engagement signal a potential shift in institutional interest or valuation expectations for Jyothy Laboratories in the coming quarter?

Nalanda India Equity Fund raises Jyothy Labs stake to 7.61%

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Nalanda India Equity Fund acquired 3,102,384 Jyothy Labs shares on Sept 2, 2026
  • Stake rose from 6.76% to 7.61% with total holding at 27,940,830 shares
  • Transaction settled on Sept 3, 2026 via exchange mechanism
  • No warrants or convertible securities involved in the acquisition
powered bylight_fuzz_icon
50048450

*this image is generated using AI for illustrative purposes only.

Nalanda India Equity Fund Limited increased its stake in Jyothy Laboratories to 7.61% following a recent share acquisition.

The Mauritius-based fund purchased 3,102,384 shares carrying voting rights on the exchange, raising its total holding from 24,838,446 shares (6.76%) to 27,940,830 shares.

Transaction Details

The acquisition was executed through open market transactions on September 2, 2026, with settlement completed on September 3, 2026. The transaction did not involve any warrants, convertible securities, or encumbered shares.

Metric Before Acquisition Acquired After Acquisition
Shares (voting rights) 24,838,446 3,102,384 27,940,830
Stake percentage 6.76% 0.85% 7.61%

Jyothy Laboratories Limited has an equity share capital of 367,214,511 shares. The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Arshad Goodur, Director at Nalanda India Equity Fund Limited, signed the disclosure form dated September 3, 2026.

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.52%-3.81%-2.19%-18.01%-40.08%+19.71%

What strategic rationale might drive Nalanda India Equity Fund to increase its stake in Jyothy Laboratories to 7.61%?

How could this increased institutional holding impact Jyothy Laboratories' stock liquidity and price volatility in the near term?

Does this acquisition signal a broader trend of foreign funds increasing exposure to Indian consumer goods stocks amid current market conditions?

More News on Jyothy Laboratories

1 Year Returns:-40.08%